Non-steroidal anti-inflammatory drug (NSAID) use in breast surgery: prospective randomised trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN06628870

Enrollment

100

Registered

2005-09-12

Start date

2005-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Cancer Breast

Interventions

Before entering operating room for breast cancer patients are randomised into two groups: 1. NSAID 2. Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Eligible patienst are women with a breast cancer undergoing modified radical mastectomy

Exclusion criteria

Exclusion criteria: 1. Known allergy or contraindication to NSAID 2. Planned immediate or late breast reconstruction

Design outcomes

Primary

Measure	Time frame
Total volume drained after modified radical mastectomy	—

Secondary

Measure	Time frame
Breast surgery complications	—

Countries

Tunisia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026